JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M408129200 on September 24, 2004 Originally published In Press as doi:10.1074/jbc.M408129200 on September 21, 2004 Originally published In Press as doi:10.1074/jbc.M408129200 on September 20, 2004

J. Biol. Chem., Vol. 279, Issue 49, 51289-51297, December 3, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/49/51289    most recent
M408129200v3
M408129200v2
M408129200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jasuja, R.
Right arrow Articles by Greenspan, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jasuja, R.
Right arrow Articles by Greenspan, D. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cell-surface Heparan Sulfate Proteoglycans Potentiate Chordin Antagonism of Bone Morphogenetic Protein Signaling and Are Necessary for Cellular Uptake of Chordin*

Reema Jasuja{ddagger}§, Benjamin L. Allen§||, William N. Pappano§||**, Alan C. Rapraeger{ddagger}{ddagger}{ddagger}§§, and Daniel S. Greenspan{ddagger}¶**{ddagger}{ddagger}¶¶

From the Programs in {ddagger}Molecular and Cellular Pharmacology and Cellular and Molecular Biology and the Departments of **Biomolecular Chemistry and {ddagger}{ddagger}Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin 53706

Signaling by bone morphogenetic proteins (BMPs) plays a central role in early embryonic patterning, organogenesis, and homeostasis in a broad range of species. Chordin, an extracellular antagonist of BMP signaling, is thought to readily diffuse in tissues, thus forming gradients of BMP inhibition that result in reciprocal gradients of BMP signaling. The latter determine cell fates along the embryonic dorsoventral axis. The secreted protein Twisted Gastrulation (TSG) is thought to help shape BMP signaling gradients by acting as a cofactor that enhances Chordin inhibition of BMP signaling. Here, we demonstrate that mammalian Chordin binds heparin with an affinity similar to that of factors known to functionally interact with heparan sulfate proteoglycans (HSPGs) in tissues. We further demonstrate that Chordin binding in mouse embryonic tissues was dependent upon its interaction with cell-surface HSPGs and that Chordin bound to cell-surface HSPGs (e.g. syndecans), but not to basement membranes containing the HSPG perlecan. Surprisingly, mammalian TSG did not bind heparin unless prebound to Chordin and/or BMP-4, although Drosophila TSG has been reported to bind heparin on its own. Results are also presented that indicate that Chordin-HSPG interactions strongly potentiate the antagonism of BMP signaling by Chordin and are necessary for the retention and uptake of Chordin by cells. These data and others regarding Chordin diffusion have implications for the paradigm of how Chordin is thought to regulate BMP signaling in the extracellular space and how gradients of BMP signaling are formed.


Received for publication, July 19, 2004 , and in revised form, September 13, 2004.

* This work was supported by National Institutes of Health Grants AR47746 and GM63471 (to D. S. G.) and Grant GM48850 (to A. C. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ These authors contributed equally to this work.

|| Predoctoral Fellow of the American Heart Association.

§§ To whom correspondence may be addressed: Dept. of Pathology and Laboratory Medicine, University of Wisconsin, 1300 University Ave., Madison, WI 53706. Tel.: 608-262-7577; Fax: 608-265-3301; E-mail: acraprae{at}wisc.edu. ¶¶ To whom correspondence may be addressed: Dept. of Pathology and Laboratory Medicine, University of Wisconsin, 1300 University Ave., Madison, WI 53706. Tel.: 608-262-4676; Fax: 608-262-6691; E-mail: dsgreens{at}wisc.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
S. A. Khan, M. S. Nelson, C. Pan, P. M. Gaffney, and P. Gupta
Endogenous heparan sulfate and heparin modulate bone morphogenetic protein-4 signaling and activity
Am J Physiol Cell Physiol, June 1, 2008; 294(6): C1387 - C1397.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
D. J. Bornemann, S. Park, S. Phin, and R. Warrior
A translational block to HSPG synthesis permits BMP signaling in the early Drosophila embryo
Development, March 15, 2008; 135(6): 1039 - 1047.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-L. Zhang, Y. Huang, L.-Y. Qiu, J. Nickel, and W. Sebald
von Willebrand Factor Type C Domain-containing Proteins Regulate Bone Morphogenetic Protein Signaling through Different Recognition Mechanisms
J. Biol. Chem., July 6, 2007; 282(27): 20002 - 20014.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Jasuja, G. Ge, N. G. Voss, J. Lyman-Gingerich, A. M. Branam, F. J. Pelegri, and D. S. Greenspan
Bone Morphogenetic Protein 1 Prodomain Specifically Binds and Regulates Signaling by Bone Morphogenetic Proteins 2 and 4
J. Biol. Chem., March 23, 2007; 282(12): 9053 - 9062.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Jiao, P. C. Billings, M. P. O'Connell, F. S. Kaplan, E. M. Shore, and D. L. Glaser
Heparan Sulfate Proteoglycans (HSPGs) Modulate BMP2 Osteogenic Bioactivity in C2C12 Cells
J. Biol. Chem., January 12, 2007; 282(2): 1080 - 1086.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
F. Rentzsch, J. Zhang, C. Kramer, W. Sebald, and M. Hammerschmidt
Crossveinless 2 is an essential positive feedback regulator of Bmp signaling during zebrafish gastrulation
Development, March 1, 2006; 133(5): 801 - 811.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
M. B. O'Connor, D. Umulis, H. G. Othmer, and S. S. Blair
Shaping BMP morphogen gradients in the Drosophila embryo and pupal wing
Development, January 15, 2006; 133(2): 183 - 193.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Glister, S. L. Richards, and P. G. Knight
Bone Morphogenetic Proteins (BMP) -4, -6, and -7 Potently Suppress Basal and Luteinizing Hormone-Induced Androgen Production by Bovine Theca Interna Cells in Primary Culture: Could Ovarian Hyperandrogenic Dysfunction Be Caused by a Defect in Thecal BMP Signaling?
Endocrinology, April 1, 2005; 146(4): 1883 - 1892.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.